Etelcalcetide

Etelcalcetide
Product Description

Specific Disclaimer. This active ingredient could be protected by a patent in force and would be therefore developed on request exclusively for the purposes stated in Article 10.6 of the Directive 2001/83/EC as amended by the Directive 2004/27/EC (Bolar provision). No activity will be performed with the active ingredients protected by a patent in force beyond the scope of the Bolar provision in any concerned jurisdiction. Nothing herein should be construed as an offer or promotion or advertisement for the sale or use of any product, if such sale or use infringes valid patents and is not authorized under applicable laws and regulations. This information is provided to you solely for your evaluation, to determine your interest in a potential relationship with Aspen Oss B.V.

Aspen Healthcare. We Care

  • NL
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Pharmaceutical Company (generic finished products)
Specifications
  • CAS Registry Number
    1262780-97-1
  • Supplied from
    Netherlands

Aspen Healthcare. We Care

  • NL
  • 2015
    On CPHI since
  • 4
    Certificates
  • 500 - 999
    Employees
Company types
CMO/CDMO
Manufacturer/Innovator
Primary activities
API Producer
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Generic APIs producer
Pharmaceutical Company (generic finished products)

More Products from Aspen Healthcare. We Care (58)

  • Testosterone undecanoate

    Product Testosterone undecanoate

    Aspen Oss B.V offers a wide range of products which includes testosterone undecanoate. Therapeutic category: steroid hormones. Contact us for more information.
  • Mirtazapine

    Product Mirtazapine

    Aspen Oss B.V offers a wide range of products which includes mirtazapine. Therapeutic category: central nervous system. Contact us for more information.
  • Rocuronium bromide

    Product Rocuronium bromide

    Aspen Oss B.V offers a wide range of products which includes rocuronium bromide. Therapeutic category: steroid hormones. Contact us for more information.
  • Azathioprine

    Product Azathioprine

    Azathioprine is part of the API portfolio of Fine Chemicals Corporation. 

    Available filings: 
    CEP/ASMF
    US-DMF 
  • Benztropine Mesylate

    Product Benztropine Mesylate

    This API is part of the FCC product portfolio
  • Cidofovir

    Product Cidofovir

    This API is part of the FCC product portfolio
  • Fluphenazine Decanoate

    Product Fluphenazine Decanoate

    This API is part of the FCC product portfolio
  • Fluphenazine Hydrochloride

    Product Fluphenazine Hydrochloride

    This API is part of the FCC product portfolio
  • Levalbuterol Hydrochloride

    Product Levalbuterol Hydrochloride

    This API is part of the FCC product portfolio
  • Methazolamide

    Product Methazolamide

    This API is part of the FCC product portfolio
  • Nomegestrol acetate

    Product Nomegestrol acetate

    Specific Disclaimer. This active ingredient could be protected by a patent in force and would be therefore developed on request exclusively for the purposes stated in Article 10.6 of the Directive 2001/83/EC as amended by the Directive 2004/27/EC (Bolar provision). No activity will be performed with the ac...
  • Noscapine on Resin

    Product Noscapine on Resin

    This API is part of the FCC product portfolio

Aspen Healthcare. We Care resources (3)

  • Sponsored Content Aspen API’s Green answer to peptide synthesis

    Our Green Continuous Liquid Phase Peptide Synthesis (GC-LPPS) combines the advantages of the classical solution-phase synthesis with the solid-phase approach. 
  • Brochure Aspen. Healthcare. We Care.

    Aspen is a global specialty and branded pharmaceutical company committed to promoting access to medicines and improving the health of patients across the world through our high quality, affordable products. Active at every stage of the value chain, we are uniquely diversified by geography, product and manufacturing capability.
  • News CPHI Trend Report - Sustainability in Pharma

    While in the past, much of the discussion around sustainability in the pharmaceutical industry rightly focused on efforts to minimize the environmental impact of drug production, the needle has now shifted. There are signs that companies not only understand that it represents one of the world’s biggest challenges moving forward, but also that they are starting to incorporate sustainability practices into a much broader suite of operations.